Refining Processes for the Co-Development of Genome-Based Therapeutics and Companion Diagnostic Tests

Idioma: inglés

Editorial: National Academies Press, US, 2014

0309298210 / 9780309298216

  • Tapa blanda
  • Nuevo
Ver todos los detalles

Librería: Rarewaves.com USA, London, London, Reino UnidoRarewaves.com USA

Vendedor de 5 estrellas

Vendedor de IberLibro desde 11 de junio de 2025

Tapa blanda

Condición: Nuevo

EUR 39,94

 Gastos de envío gratis 
Se envía de Reino Unido a Estados Unidos de America

Cantidad disponible: 1 disponible

Añadir al carrito
Devoluciones gratuitas de 30 días

Descripción del artículo del vendedor

Many drug developers have examined new strategies for creating efficiencies in their development processes, including the adoption of genomics-based approaches. Genomic data can identify new drug targets for both common and rare diseases, can predict which patients are likely to respond to a specific treatment, and has the potential to significantly reduce the cost of clinical trials by reducing the number of patients that must be enrolled in order to demonstrate safety and efficacy. A key component of the approval of targeted therapeutics is the ability to identify the population of patients who will benefit from treatment, and this has largely hinged on the co-development and co-submission to the FDA of a companion diagnostic test.The co-development process, or the development of the test and drug for the simultaneous submission to FDA, has led to a major alteration in the way that drugs are being developed, with traditionally separate entities-pharmaceutical and diagnostic companies-now working in close collaboration.Refining Processes for the Co-Development of Genome-Based Therapeutics and Companion Diagnostic Tests is the summary of a workshop held by the Roundtable on Translating Genomic-Based Research for Health on February 27, 2013 to examine and discuss challenges and potential solutions for the codevelopment of targeted therapeutics and companion molecular tests for the prediction of drug response. Prior to the workshop, key stakeholders, including laboratory and medical professional societies, were individually asked to provide possible solutions to resolve the concerns raised about co-development of companion diagnostic tests and therapies. Workshop speakers were charged with addressing these solutions in their presentations by providing insight on (1) whether the proposed solutions address the problems described, (2) whether there are other solutions to propose, and (3) what steps could be taken to effectively implement the proposed solutions.…

N° de ref. del artículo LU-9780309298216

Título
Refining Processes for the Co-Development of Genome-Based Therapeutics and Companion Diagnostic Tests
Autor
Author Stated, No
Editorial
National Academies Press, US
Año de publicación
2014
Estado
New
Encuadernación
Paperback
Idioma
inglés
ISBN 10
0309298210
ISBN 13
9780309298216

Rarewaves.com USA

London, London, Reino Unido

Vendedor de 5 estrellas

Vendedor de IberLibro desde 11 de junio de 2025

Tarifas de envío de Reino Unido a Estados Unidos de America

ArtículoDe 7 a 12 días hábilesDe 7 a 12 días hábiles
Primer artículoEUR 0,00EUR 0,00
Los plazos de entrega los establecen los vendedores y varían según el transportista y la ubicación. Los pedidos que pasan por la aduana pueden sufrir retrasos y los compradores son responsables de los aranceles o tarifas asociadas. Los vendedores pueden ponerse en contacto con usted en relación con cargos adicionales para cubrir cualquier aumento en los costes de envío de los artículos.

Métodos de pago

  • Visa
  • Mastercard
  • American Express
  • Carte Bleue
  • Apple Pay
  • Google Pay

Información empresarial del vendedor

RAREWAVES.COM LIMITED

Elsley Court, 20-22 Great Titchfield Street
London, Reino Unido W1W 8BE